Cordance Medical accepted into Creative Destructive Labs Neurology Accelerator

Cordance accepted into the only Neurology focused accelerator

Mountain View, Calif. – Cordance Medical has been accepted into the prestigious Creative Destructive Labs (CDL) neurology track.  The CDL is a multi-national accelerator with locations across the globe seeking out top seed-stage technology companies.

“Acceptance into the CDL-Neurology program is an incredible accomplishment,” said Ryan Dittamore, CEO at Cordance Medical. “Gaining access to such a strong group of neurology-based mentors and financiers positions us extremely well to execute.”

The CDL-Neurology program encompasses in-person objective-setting sessions between October and June.  The program is intended for companies pursuing commercial opportunities in brain science to improve human health and quality of life.  The program is run through the University of Toronto Rotman School of Management.  Cordance will gain access to top neurology mentors, financiers, and business services to position the company for growth and execution as part of the program.